Company Overview
Snapshot
Founded in October 2019 by Nati Nachmany, Centrefy operates with 1–10 employees. The company is currently in a Pre-Funding stage, having ceased operations in December 2025.
Business overview
Centrefy develops a holistic solution leveraging AI and machine vision technologies to enhance medication adherence and treatment outcomes. Its proactive health companion, Victor, monitors patient progress, predicts treatment outcomes, and supports the entire drug consumption cycle by collecting and analyzing data and digital biomarkers. The platform aims to provide meaningful insights into patient health, predict deterioration related to hospitalization and medication nonadherence, and integrates with IoT devices to improve adherence and data analysis. Centrefy serves the Health Tech & Life Sciences sector, focusing on digital healthcare, patient engagement, and pharmaceutical industries.
Company Intelligence Q&A
- What is Centrefy's primary focus?
- Centrefy focuses on developing a holistic solution to improve medication adherence and treatment outcomes through innovative technology.
- When was Centrefy founded?
- Centrefy was founded in October 2019.
- Who is the founder of Centrefy?
- Nati Nachmany is the Co-founder & CEO of Centrefy.
- What is the core technology behind Centrefy's solution?
- Centrefy's solution, Victor, utilizes AI and machine vision technologies to monitor patient progress and predict treatment outcomes.
- What is the current operational status of Centrefy?
- Centrefy ceased to operate in December 2025.